Status:
COMPLETED
Detection of Lung Cancer by Plasma Lipids
Lead Sponsor:
Peking University People's Hospital
Collaborating Sponsors:
Beijing Haidian Hospital
Jiangsu Cancer Institute & Hospital
Conditions:
Early-Stage Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
There are no reliable blood-based tests currently available for early-stage lung cancer diagnosis. We try to establish a highly accurate method for detecting early-stage lung cancer by combining machi...
Detailed Description
All plasma lipids were first detected by untargeted metabolomics methods and 9 feature lipids of early-stage lung cancer were selected by support vector machine algorithm. Then, a targeted metabolomic...
Eligibility Criteria
Inclusion
- pulmonary nodules or opacity
- plan to receive surgery
Exclusion
- history of other malignancies
- received anti-cancer treatment (chemotherapy, radiotherapy, targeted therapy, etc.) before surgery
Key Trial Info
Start Date :
December 13 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 20 2020
Estimated Enrollment :
558 Patients enrolled
Trial Details
Trial ID
NCT04287712
Start Date
December 13 2018
End Date
May 20 2020
Last Update
June 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's Hospital
Beijing, Beijing Municipality, China, 100044